134 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
to the Company’s by-laws, your successor is elected and duly qualified, or until your earlier death, disability resignation or removal. If at any time … Outside of the Change in Control Period. If the Company terminates your employment without Cause (and not as a result of your death or Disability) or you
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
(and not as a result of your death or Disability) outside of the Change in Control Period (as such capitalized terms are defined in Appendix … Within the Change in Control Period. If the Company terminates your employment without Cause (and not as a result of your death or Disability) within
8-K
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
. In addition, in the event of his termination due to death or disability, Dr. Klein’s Amended Agreement provides for accelerated vesting of all
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
, vacation pay, salary continuation for disability, retirement benefits, deferred compensation, bonus pay, incentive pay, stock options or other stock
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
, any successor corporation.
(m) “Disability” has the meaning set forth in a written employment, offer, services or severance agreement or letter … by reason of any medically determinable physical or mental impairment. A determination of Disability shall be made by the Committee on the basis
8-K
EX-10.16
caszydphw7c
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.1
aqgc0e8l e71jyj3
4 Apr 24
Departure of Directors or Certain Officers
4:30pm
425
6w39r
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
lw7r44f
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am